Dr. Chandran is a rheumatologist and clinician-scientist, an Assistant Professor of Medicine & Laboratory Medicine and Pathobiology at the University of Toronto, an affiliate scientist at the Krembil Research Institute, a staff physician at the University Health Network and Mount Sinai Hospitals, and an associate member of the graduate faculty at the Institute of Medical Science. He co-directs the Psoriatic Arthritis Program at the University Health Network.
Dr. Chandran’s research interests lie in the genetic and molecular epidemiology of psoriasis and psoriatic arthritis, especially with respect to prognosis. His current research is focused on developing a soluble biomarker-based screening and prognostic tool for psoriatic arthritis, as well as identifying and reducing barriers to multidisciplinary care of patients with spondyloarthritis. His bench research aims to identify mechanisms underlying inflammation and joint damage in psoriatic arthritis.